Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy.
about
Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's diseaseChronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system.Implications of lipid biology for the pathogenesis of schizophrenia.Bioactive lipids in schizophrenia.Apolipoproteins in the brain: implications for neurological and psychiatric disorders.Functional genomics in neuropsychiatric disorders and in neuropharmacology.Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders.Microarray technologies 2003 -- an overview.The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems.Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatmentHeterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia.Understanding aberrant white matter development in schizophrenia: an avenue for therapy?Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain.Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins.Apolipoprotein D mRNA expression is elevated in PDAPP transgenic mice.Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene.Apolipoprotein D is associated with long-term outcome in patients with schizophrenia.Apolipoprotein D expression in human brain reactive astrocytes.Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
P2860
Q28507781-618BAE40-814C-4F1F-98D2-6153D8C69A7BQ28590486-031639AF-28DA-46B5-9B7A-74E1AE535AB7Q30697695-A5140764-8357-4D2D-89EC-88F910A5FADAQ33246888-439DEAAE-8BE7-46AA-9549-CD4DC7BB3FAEQ34680878-98E58443-FDF0-4BE7-90A7-D0662E316CC8Q34837434-35631152-8039-4235-902F-5C430BFA6F10Q35053593-29AA3241-881A-46FD-963D-57AC564A5EA6Q35116080-DD1EE9ED-4D04-42C7-A588-DD26E14E1A97Q35975087-F2C4D4C5-D3E6-410C-8596-C0936162EAB8Q36435854-A180F71F-0271-4898-8A46-FFE2DF4668BAQ36927513-ECD92FB9-2A9D-4901-81C3-5E01DDAC8FEBQ37088528-4F8CBB1F-1971-4A2F-8D76-5864607C012BQ37896626-70CBCF27-2CC1-4D9B-BD5C-270EE9739E23Q38194683-CE3D5609-9904-4242-A782-2E3AF1E3C61FQ38347364-ADE77A3A-E658-4D1E-B340-7FE5F3A427E5Q43427884-A1057387-1B53-4CAE-AAA5-7583D4E66D93Q44334386-47B1906C-7DE3-44D3-99E7-C1F02E1455BAQ46886435-91090049-44DD-4631-BA21-FAE4ED5726B7Q48193614-2BCBF52E-DE28-41AD-B821-12058650A7BBQ48377734-7058CEFA-FCE7-4E8B-8737-73D1688D0A3D
P2860
Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clozapine increases apolipopro ...... r neuroleptic pharmacotherapy.
@ast
Clozapine increases apolipopro ...... r neuroleptic pharmacotherapy.
@en
type
label
Clozapine increases apolipopro ...... r neuroleptic pharmacotherapy.
@ast
Clozapine increases apolipopro ...... r neuroleptic pharmacotherapy.
@en
prefLabel
Clozapine increases apolipopro ...... r neuroleptic pharmacotherapy.
@ast
Clozapine increases apolipopro ...... r neuroleptic pharmacotherapy.
@en
P2093
P2860
P1476
Clozapine increases apolipopro ...... r neuroleptic pharmacotherapy.
@en
P2093
Danielson PE
Hilbush BS
Sutcliffe JG
P2860
P304
P356
10.1046/J.1471-4159.2001.00027.X
P407
P577
2001-02-01T00:00:00Z